The promise of improving patient care and outcomes through RWD has been understood for some time, but overcoming the fragmentation and inaccessibility of disparate data sources across disease states has proven to be a hard challenge across the industry. We’re not learning fast enough— this is where clinical expert-led AI can help.
By using AI to standardize unprecedented volumes of data, uncover clinical details that have previously been hidden in free text notes, and represent full patient journeys in near real-time, researchers can ask and answer complex questions for targeted populations like never before.
During this session, experts from UCB and Truveta will:
- Examine longitudinal patient journeys on nearly 100 million patients within EHR, SDOH, mortality, and claims data across diseases, drugs, and devices
- Demonstrate the power of AI-driven extraction of critical information from free text clinical notes that were previously inaccessible
- Showcase recent research on full patient journey analysis in relatively rare conditions by accessing deep EHR data from multiple care settings and specialties
Click here to find additional details and registration information.
Related Content
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
The role of patient-centric technologies & tokenization in RWE studies
Join the Castor team on the 3rd May 2023 with Aaron Berger from UBC & Ryan Moog from Datavant where we will dive deep into all things RWE, patient-centric technologies and the role of tokenization in clinical trials. You will hear about RWE case studies from the experts, learn new trends in the adoption of DCTs and how the role of patient-centric technologies & tokenization can contribute to successful RWE studies.